Human Albumin Baxalta

Human Albumin Baxalta, containing human serum albumin as the active ingredient, is supplied as a sterile intravenous solution intended for clinical use in the European Union. It is classified as a plasma volume expander and is administered under prescription to support patients with conditions that require rapid restoration of intravascular volume.

Human Albumin Baxalta is used in medical settings to address conditions where plasma volume needs to be quickly restored. It is commonly employed in the following situations:

- Management of hypovolemia due to blood loss or dehydration - Treatment of circulatory shock of various etiologies - Support for patients with extensive burns - Correction of hypoalbuminemia associated with liver disease or nephrotic syndrome - Adjunct therapy during major surgery to maintain oncotic pressure

Adverse reactions to Human Albumin Baxalta can vary in frequency and severity.

Common: - Fever or chills - Transient hypotension or hypertension - Mild rash or urticaria - Headache - Nausea

Serious: - Anaphylactic or severe allergic reaction - Volume overload leading to pulmonary edema - Acute hemolysis (rare) - Thromboembolic events - Severe hypertension with cardiovascular compromise

Human Albumin Baxalta should be used with careful clinical assessment and monitoring. Important precautions include: - Evaluate fluid status and avoid administration in patients with congestive heart failure or severe renal impairment. - Monitor for signs of allergic reactions during and after infusion. - Use caution in patients with known hypersensitivity to albumin or blood products. - Adjust dosage in patients with altered plasma protein levels. - Ensure proper storage and handling to maintain product integrity. - Verify compatibility with other intravenous solutions before co‑administration.

Human Albumin Baxalta may interact with other therapies, influencing safety or efficacy.

Avoid: - Co‑administration with other volume expanders that may cause fluid overload. - Simultaneous infusion of high‑dose diuretics without monitoring.

Use with caution: - Concurrent use of vasopressors, as albumin can affect blood pressure responses. - Administration alongside anticoagulants, requiring close observation for bleeding. - Combination with nephrotoxic agents, due to potential changes in renal perfusion. - Use with other plasma proteins, which may alter oncotic balance. - Infusion with blood products, necessitating compatibility checks.